Mastitis is a breast infection, which results in breast pain, swelling, warmth, and redness. In most cases, lactation mastitis occurs within the first six to 12 weeks after giving birth (postpartum), but it can happen later during the breastfeeding. The major symptoms of mastitis include breast tenderness or warmth to the touch, malaise, breast swelling, pain or a burning sensation continuously or while breastfeeding, skin redness, often in a wedge-shaped pattern, high fever and others.



According to the WHO, breast cancer is the second most common type of cancer in women. Every year 200,000 new cases are diagnosed worldwide and the number is continuously increasing. Prevalence of breast cancer is more common in developed countries as compared to developing countries. The global breast cancer market is driven by increasing number of females having breast cancer. Adoption of an unhealthy lifestyle, exposure to harmful radiation, increasing female geriatric population, and increasing government initiatives also contributed to the growth of the market. Since no absolute treatment is available to completely cure the disease, there is a scope for developing effective treatments. On another hand, the high cost of the treatment, adverse effects associated with the therapy, and long approval time for the drugs may restrain the growth of the market. However, the high cost of the treatment is likely to affect the growth of the market, negatively.

Get Exclusive PDF Sample Report @ https://www.marketresearchfuture.com/sample_request/5379

Key Players for Mastitis Market:

Pfizer (U.S.), Novartis AG (Switzerland), Oncogenex (U.S.), Apthera Inc (U.K), BioNumerik Pharmaceuticals (U.S.), Oncothyreon Inc (US), Astellas (Japan), Bipar Sciences (U.S.), Puma Biotechnology (U.S.), Sanofi S.A. (U.S.), Eli Lilly and Company (U.S.), AstraZeneca (UK), F. Hoffmann-La Roche (Switzerland), GlaxoSmithKline (U.K), Genentech (U.S), Teva Pharmaceutical Industries (Israel), Sun Pharmaceutical Industries Ltd (India), Accord Healthcare, Inc. (India), Gilead Sciences, Inc. (U.S.), and others.

Intended Audience

Pharmaceutical and Biotechnological Companies
Research and Development (R&D) Companies
Neurological Companies
Hospitals and Clinics
Academic Institutes and Universities
Segments for Global Mastitis Market:

The global mastitis market is segmented on the basis of types, diagnosis, treatment, and end-users. Based on the types, the market is segmented into contagious mastitis and environmental mastitis. On the basis of the diagnosis, the market is segmented into the physical examination and others. On the basis of the treatment, the market is segmented into antibiotics, pain relievers, surgery, and others. The pain relievers are further segmented into acetaminophen, ibuprofen, and others. Moreover, the acetaminophen is segmented into Tylenol and others. Ibuprofen is further segmented into Advil, Motrin IB, and others. On the basis of the end users, the market is segmented into hospital & clinics, research centers, and others.



Regional Analysis for Global Mastitis Market:

The Americas mastitis market is expected to show extensive growth owing to increasing number of patient population for mastitis, and technological advancement in the healthcare. Moreover, high health care spending and increasing government support for research & development are expected to boost the market growth.

Europe holds the second largest share of the global market. The increasing focus of various government agencies on treating mastitis, and increasing investment in healthcare domain to improve treatment methods of rare diseases will fuel the growth of the market. The growing public awareness will boost the European market.

The Asia Pacific is the fastest growing mastitis market across the globe. Japan holds the major share of the regional market due to the availability of technology and huge healthcare spending. Rapidly developing the economy, increasing healthcare expenditure, and government initiatives for research & development are projected to drive the market in China and India over the assessment period. Alongside, there is a huge growth outlook for the market in the developing countries as these countries are encouraging research and development in healthcare management.

The Middle East and Africa hold the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market whereas, the African region is expected to witness a moderate growth.

Get Prime Discount on Report @ https://www.marketresearchfuture.com/check-discount/5379

Some Brief Table of Contents of Report

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants


TOC Continued…


Do You Have Specific Requirement? Ask to Our Experts @ https://www.marketresearchfuture.com/enquiry/5379


About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.



Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: [email protected]